565 - Parental views on the acceptability of waiver of consent in neonatal clinical trials: the FAM-CONNECT study

Elliott M. Weiss, University of Washington, Seattle, WA, United States; Abril Beretta, Seattle Children's, seattle, WA, United States; Andrea Kelsh, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, United States; Sandhya Subramanian, NA, Seattle, WA, United States; Simran Sekhon, NA, KENT, WA, United States; Laura Heck, Seattle Children's, Covington, WA, United States; Ben A. Mooso, University of California, San Diego School of Medicine, La Jolla, CA, United States; Justin Clapp, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States; Neal W. Dickert, Emory University School of Medicine, Atlanta, GA, United States; Anup Katheria, Sharp Mary Birch Hospital for Women & Newborns, San Diego, CA, United States; Katherine Guttmann, Icahn School of Medicine at Mount Sinai, New York, NY, United States; Stephanie K.. Kukora, Children's Research Institute, Children's Mercy Hospital, Children's Mercy, Kansas City, MO, United States; Diana Montoya-Williams, Children’s Hospital of Philadelphia, Philadelphia, PA, United States; Kaashif A. Ahmad, Pediatrix Medical Group, Houston, TX, United States; Rebecca A. Dorner, Sharp Mary Birch Hospital for Women & Newborns, San Diego, CA, United States; Muntasir Natour, Children's Hospital Los Angeles, Los Angeles, CA, United States; Stephanie A. Kraft, Geisinger, Danville, PA, United States